CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. (CARM) Stock Price Target 2026

The average analyst price target for CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. is $0.90, 128471.4% above the current price. Of 6 analysts, 2 rate it Buy and 4 Hold. Targets range from $0.70 to $1. The latest change came on Apr 1, 2025, when D. Boral Capital lowered its price target on CARISMA THERAPEUTICS INC by Carisma Therapeutics, Inc. from $12 to $1 and kept a Buy rating.